The value of the Van Nuys Prognostic Index in ductal carcinoma in situ of the breast: A retrospective analysis

被引:25
作者
Asjoe, Fernando Tjin
Altintas, Sevilay
Huizing, Manon. T.
Colpaert, Cecile
Van Marck, Erik
Vermorken, Jan B.
Tjalma, Wiebren A.
机构
[1] Univ Antwerp Hosp, Dept Gynecol & Gynecol Oncol, Edegem, Belgium
[2] Univ Antwerp Hosp, Dept Med Oncol, Edegem, Belgium
[3] Univ Antwerp Hosp, Dept Pathol, Edegem, Belgium
关键词
ductal carcinoma in situ; prognostic factors; Van Nuys Prognostic Index;
D O I
10.1111/j.1524-4741.2007.00443.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Van Nuys Prognostic Index 1996 (VNPI), based upon tumor size, pathological grade and tumor margins, is a guideline for the treatment of ductal carcinoma in situ (DCIS). It was thought to strongly decrease overtreatment. In 2003, age was added to the index as a fourth prognostic factor. We examined changes in treatment modality after applying the VNPI retrospectively and investigated if the addition of age to the Index causes a shift in treatment. The influence of each prognostic factor on disease-free survival (DFS) was calculated. We performed a retrospective file study of DCIS patients treated between 1985 and 2003 at the University Hospital, Antwerp. Patients were assigned a Van Nuys Score 1996 and 2003. The influence of tumor size, pathological grade, tumor margins and age on DFS was calculated with the Kaplan-Meier method and the log-rank test. We identified 104 DCIS cases with a median follow-up of 36 months. Twelve patients showed recurrence (11.5%), of whom seven were invasive (58%). Seventeen of the 29 women diagnosed before 1997 were undertreated according to the VNPI 1996 and six of them showed recurrence. The remaining three recurrences were correctly treated. Seventy-five patients diagnosed after 1997 were all treated according to the VNPI 1996 and only three had a recurrence. The introduction of age caused no significant shift in treatment modalities. Significant differences in DFS were seen between large (> 41 mm) and small (< 15 mm) tumors (p = 0.0074), old (> 60 years) and young (< 40 years) patients (p = 0.024) and Van Nuys Subgroup 2 and 3 (p = 0.04). Tumor margins and pathological grade showed no significant difference in DFS. The VNPI can be a useful tool in the treatment of DCIS. However, this Index is not evidence-based, using a relatively small retrospective series of patients. The validity of the modified VNPI must be prospectively confirmed with large numbers of DCIS patients.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 45 条
[1]   Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. [J].
Bartelink, H ;
Horiot, J ;
Poortmans, P ;
Struikmans, H ;
Van den Bogaert, W ;
Barillot, I ;
Fourquet, A ;
Borger, J ;
Jager, J ;
Hoogenraad, W ;
Collette, L ;
Pierart, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) :1378-1387
[2]   Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853 [J].
Bijker, N ;
Peterse, JL ;
Duchateau, L ;
Julien, JP ;
Fentiman, IS ;
Duval, C ;
Di Palma, S ;
Simony-Lafontaine, J ;
de Mascarel, I ;
van de Vijver, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2263-2271
[3]  
Boyages J, 1999, CANCER, V85, P616, DOI 10.1002/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.3.CO
[4]  
2-Z
[5]  
BUR ME, 1992, CANCER-AM CANCER SOC, V69, P1174
[6]  
CHAUDURI B, 1993, SURGERY, V113, P134
[7]  
Dowlatshahi K, 1999, CANCER, V86, P990, DOI 10.1002/(SICI)1097-0142(19990915)86:6<990::AID-CNCR14>3.3.CO
[8]  
2-4
[9]  
FAVERLY DRG, 1994, SEMIN DIAGN PATHOL, V11, P193
[10]   Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience [J].
Fisher, B ;
Land, S ;
Mamounas, E ;
Dignam, J ;
Fisher, ER ;
Wolmark, N .
SEMINARS IN ONCOLOGY, 2001, 28 (04) :400-418